EUVIMEDEUVIMED entdecken
Crossref

Novel Cinnamic Acid Derivatives Containing Naproxen as NLRP3 Inhibitors: Synthesis and Evaluation of Their Biological Activity

Jialin Yu, Zonglin You, Vincent Kam Wai Wong, Min Chen, Wenfeng Liu iD

Chemistry & Biodiversity · 2025-05 · 22 (5)

DOI: 10.1002/cbdv.202402700 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 07.01.2025. Verfasst von Jialin Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Food Engineering, Wuyi University, Jiangmen, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Cinnamates, Naproxen, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long‐term use of naproxen can lead to serious side effects. Inspired by the biological activity of cinnamic acid, a series of cinnamic acid derivatives containing naproxen were designed and synthesized, and their anti‐inflammatory activities and mechanisms were explored in vitro. Our results indicated that all of naproxen derivatives showed more significant inhibition against lipopolysaccharide (LPS)‐induced nitric oxide (NO) production and had a lower degree of cytotoxicity than that of naproxen. The present studies revealed that compound 23 (IC 50 = 5.66 ± 1.66 µM) markedly inhibited the LPS‐induced NO production and the over‐expression of pro‐inflammatory cytokines, including interleukin (IL)‐1β, inducible NO synthase (iNOS), and cyclooxygenase‐2 (COX‐2). Furthermore, it blocked the activation of NF‐κB signaling pathway and pyrin domain‐containing protein 3 (NLRP‐3) inflammasome in a concentration‐dependent manner. Additionally, docking studies confirmed that compound 23 exhibited a well‐fitting into the NLRP3 active site. Considering these results, compound 23 might be a novel NLRP3 inhibitor to treat inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinCinnamatesNaproxenAnti-Inflammatory Agents, Non-SteroidalAnti-Inflammatory AgentsNitric OxideMolecular Docking SimulationLipopolysaccharidesStructure-Activity RelationshipMiceAnimalsMolecular StructureDose-Response Relationship, DrugHumansNF-kappa BInflammasomesSignal TransductionRAW 264.7 Cells

Stichwörter der Autor:innen

cinnamic acidnaproxen derivativespro‐inflammatory cytokinespyrin domain‐containing protein 3

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinCinnamatesNaproxencinnamic acidNitric OxideLipopolysaccharidesNF-kappa BInflammasomesAnti-Inflammatory Agents, Non-SteroidalAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Pharmacy and Food Engineering, Wuyi University, Jiangmen, China.
  • Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.

ORCID-Profile: Wenfeng Liu

Zitieren

APA

Yu, J., You, Z., Wong, V. K. W., Chen, M., & Liu, W. (2025). Novel Cinnamic Acid Derivatives Containing Naproxen as NLRP3 Inhibitors: Synthesis and Evaluation of Their Biological Activity. Chemistry & Biodiversity, 22(5). https://doi.org/10.1002/cbdv.202402700

Vancouver

Yu J, You Z, Wong VKW, Chen M, Liu W. Novel Cinnamic Acid Derivatives Containing Naproxen as NLRP3 Inhibitors: Synthesis and Evaluation of Their Biological Activity. Chemistry & Biodiversity. 2025;22(5). doi:10.1002/cbdv.202402700

BibTeX
@article{Yu2025,
  author = {Yu, Jialin and You, Zonglin and Wong, Vincent Kam Wai and Chen, Min and Liu, Wenfeng},
  title = {Novel Cinnamic Acid Derivatives Containing Naproxen as NLRP3 Inhibitors: Synthesis and Evaluation of Their Biological Activity},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  volume = {22},
  number = {5},
  doi = {10.1002/cbdv.202402700}
}
Kostenlos starten →